Gene · 1063
Papers2,501
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,501
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retrospective identification of intrinsic factors that mark pluripotency potential in rare somatic cells. | bioRxiv | 2023 | 36798299 | PubTator, text mining | PubMed |
| Impaired protein hydroxylase activity causes replication stress and developmental abnormalities in humans. | J Clin Invest | 2023 | 36795492 | PubTator, text mining | PubMed |
| Identification of Differentially Methylated Genes Associated with Clear Cell Renal Cell Carcinoma and Their Prognostic Values. | J Environ Public Health | 2023 | 36793506 | PubTator, text mining | PubMed |
| KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma. | Front Oncol | 2023 | 36776306 | PubTator, text mining | PubMed |
| A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle. | Molecules | 2023 | 36770809 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Analysis Reveals a Cell Atlas and Cell Communication in Yak Ovary. | Int J Mol Sci | 2023 | 36768166 | PubTator, text mining | PubMed |
| Aurora B SUMOylation Is Restricted to Centromeres in Early Mitosis and Requires RANBP2. | Cells | 2023 | 36766713 | PubTator, text mining | PubMed |
| AKR1C2 Promotes Metastasis and Regulates the Molecular Features of Luminal Androgen Receptor Subtype in Triple Negative Breast Cancer Cells. | J Breast Cancer | 2023 | 36762781 | PubTator, text mining | PubMed |
| Hsa_circ_0001925 promotes malignant progression in triple-negative breast cancer via miR-1299/YY1 axis. | Thorac Cancer | 2023 | 36754085 | PubTator, text mining | PubMed |
| CENPF knockdown inhibits adriamycin chemoresistance in triple-negative breast cancer via the Rb-E2F1 axis. | Sci Rep | 2023 | 36720923 | PubTator, text mining | PubMed |
| Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics. | Biomed Res Int | 2023 | 36714024 | PubTator, text mining | PubMed |
| Whole-exome sequencing identified recurrent and novel variants in benzene-induced leukemia. | BMC Med Genomics | 2023 | 36703207 | PubTator, text mining | PubMed |
| NCAPD2 is a novel marker for the poor prognosis of lung adenocarcinoma and is associated with immune infiltration and tumor mutational burden. | Medicine (Baltimore) | 2023 | 36701707 | PubTator, text mining | PubMed |
| 5-mRNA-based prognostic signature of survival in lung adenocarcinoma. | World J Clin Oncol | 2023 | 36699627 | PubTator, text mining | PubMed |
| The genetic background of hydrocephalus in a population-based cohort: implication of ciliary involvement. | Brain Commun | 2023 | 36694575 | PubTator, text mining | PubMed |
| Engineering placenta-like organoids containing endogenous vascular cells from human-induced pluripotent stem cells. | Bioeng Transl Med | 2023 | 36684087 | PubTator, text mining | PubMed |
| Stemness-related genes revealed by single-cell profiling of naïve and stimulated human CD34+ cells from CB and mPB. | Clin Transl Med | 2023 | 36683248 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing and deep tissue proteomics reveal distinct tumour microenvironment in stage-I and II cervical cancer. | J Exp Clin Cancer Res | 2023 | 36683048 | PubTator, text mining | PubMed |
| The HIPK2/CDC14B-MeCP2 axis enhances the spindle assembly checkpoint block by promoting cyclin B translation. | Sci Adv | 2023 | 36662865 | PubTator, text mining | PubMed |
| Lung Cancer Gene Regulatory Network of Transcription Factors Related to the Hallmarks of Cancer. | Curr Issues Mol Biol | 2023 | 36661515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1063/papers?page=20